Oramed Pharmaceuticals, Inc

NASDAQ:ORMP   3:59:54 PM EDT
10.73
+0.43 (+4.18%)
Products, Regulatory

Oramed Enters Into Clinical Research Organization Services Agreement With Integrium

Published: 09/09/2020 21:53 GMT
Oramed Pharmaceuticals, Inc (ORMP) - Oramed Pharmaceuticals Inc - on September 2, Unit Entered Into a Clinical Research Organization Services Agreement With Integrium.
Oramed Pharmaceuticals Inc - to Retain Integrium As a Clinical Research Organization for Subsidiary's Planned Upcoming Phase 3 Clinical Trial.
Oramed Pharmaceuticals Inc - Unit Will Pay Integrium About $21.6 Million That Will Be Paid Over Term of Engagement.